Select the name of the type of clinical care program you would like more information about …

Example: ‘B’ for Bladder Cancer

Cancer Treatment A-Z

Skip to content. | Skip to navigation

Personal tools

Navigation

You are here: Home / Training / Seminars and Symposia / The RhoGEF GEF-H1 is required for oncogenic RAS signaling

The RhoGEF GEF-H1 is required for oncogenic RAS signaling

Robert Rottapel, MD, Sr. Scientist, Princess Margaret Cancer Center, Professor, University of Toronto
When Jan 28, 2014
from 04:00 PM to 05:00 PM
Where 1131 Bioinformatics
Add event to calendar iCal

Department of Pharmacology
Hosted by  Dr. Klaus Hahn